You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma

Showing 1 - 25 of 8,117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Local and Peripheral Immune Responsive Landscape Induced by

Not yet recruiting
  • Lung Adenocarcinoma
  • Local Cryoablation
    • (no location specified)
    Oct 24, 2023

    Lung Adenocarcinoma, Frozen Section, Sublobar Resection Trial in Shanghai (Sublobar Resection)

    Recruiting
    • Lung Adenocarcinoma
    • +2 more
    • Sublobar Resection
    • Shanghai, Shanghai, China
      Fudan University Cancer Center
    Sep 4, 2023

    Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

    Not yet recruiting
    • Gastric Adenocarcinoma
    • cadonilimab combined +paclitaxel (albumin-bound)
    • (no location specified)
    Nov 1, 2023

    Tumor Microenvironment

    Active, not recruiting
    • Lung Adenocarcinoma
      • (no location specified)
      Aug 5, 2023

      HER-2 Expression in Pancreatic Duct Adenocarcinoma

      Completed
      • Pancreatic Adenocarcinoma
      • immunohistochemical approach
      • (no location specified)
      Sep 20, 2023

      Colorectal Adenocarcinoma Trial in Padova (Impact Oral®)

      Not yet recruiting
      • Colorectal Adenocarcinoma
      • Impact Oral®
      • Padova, Italy
        Istituto Oncologico Veneto IRCCS
      Nov 10, 2023

      Invasiveness for Small-sized Lung Adenocarcinoma

      Recruiting
      • Lung Adenocarcinoma, Stage I
      • Invasiveness diagnosis
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Apr 13, 2023

      Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

      Not yet recruiting
      • Adenocarcinoma Esophagus
      • +3 more
      • (no location specified)
      Sep 13, 2023

      Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

      Not yet recruiting
      • Esophagogastric Adenocarcinoma
      • Sacituzumab govitecan
      • (no location specified)
      Nov 9, 2023

      IA Lung Adenocarcinoma, Combined Segmentectomy Trial in Fuzhou (Patients receive subsegmentectomy)

      Active, not recruiting
      • IA Lung Adenocarcinoma
      • Combined Segmentectomy
      • Patients receive subsegmentectomy
      • Fuzhou, China
        Fujian Medical University Union Hospital
      Aug 2, 2023

      Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

      Not yet recruiting
      • Pancreas Adenocarcinoma
      • +2 more
      • Nab paclitaxel
      • +3 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      Apr 19, 2023

      Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced

      Recruiting
      • Gastric Cancer
      • Gastric Adenocarcinoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Apr 4, 2023

      Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

      Recruiting
      • Lung Adenocarcinoma
      • Shijiazhuang, Hebei, China
        The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
      Sep 24, 2023

      Segmentectomy Versus Lobectomy for Lung Adenocarcinoma = 2cm

      Recruiting
      • Lung Adenocarcinoma
      • Lobectomy with systemic lymph node dissection
      • Segmentectomy with systemic lymph node dissection
      • Yangpu, Shanghai, China
        Shanghai Pulmonary Hospital
      Apr 20, 2023

      Advanced Adenocarcinoma Trial (BA3182)

      Not yet recruiting
      • Advanced Adenocarcinoma
      • (no location specified)
      Apr 10, 2023

      Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)

      Not yet recruiting
      • Gastroesophageal Adenocarcinoma
      • (no location specified)
      Sep 12, 2023

      Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

      Recruiting
      • Gastric Adenocarcinoma
      • Adenocarcinoma of Gastroesophageal Junction
      • Docetaxel for injection (Albumin-bound)
      • Taxotere
      • Guangzhou, China
        Ethics Committee of Sun-Yat-Sen University Cancer Center
      Jan 27, 2023

      Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

      Not yet recruiting
      • Adenocarcinoma - GEJ
      • Gastric Adenocarcinoma
      • (no location specified)
      Sep 26, 2023

      Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

      Recruiting
      • Gastroesophageal Junction Adenocarcinoma
      • Beijing, China
        Peking Union Medical College Hospital
      Jun 15, 2023

      Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Oligometastatic Disease
      • FOLFIRINOX chemotherapy
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Nov 2, 2023

      Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

      Not yet recruiting
      • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
      • (no location specified)
      Jul 17, 2023

      Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With

      Not yet recruiting
      • Third-line Treatment
      • +2 more
      • furquimatinib and sintilimab
      • (no location specified)
      Mar 30, 2023

      Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • Enfortumab vedotin
      • Kansas City, Kansas
        University of Kansas Cancer Center
      Jun 23, 2023

      Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)

      Not yet recruiting
      • Ethmoid Sinus Tumor
      • +2 more
      • Liquid biopsy
      • (no location specified)
      Oct 18, 2023

      Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

      Recruiting
      • Adenocarcinoma of Stomach
      • Gentuximab Injection
      • Gentuximab Injection Placebo
      • Shanghai, Shanghai, China
        Shanghai Dongfang Hospital
      Jun 16, 2023